Early benefit assessment of medications

The price of new drugs in Germany depends on the result of the so-called early benefit assessment. The legal basis for this is the “Act on the Reform of the Market for Medicinal Products (AMNOG).” Here you can find information on medications that have been assessed by the German Institute for Quality and Efficiency in Health Care (IQWiG, Germany) in the last few years.

Early benefit assessment of medications from A to Z

Popular in Early benefit assessment of medications